Gordon Strathdee
Centre for Oncology and Applied Pharmacology
CR-UK Beatson Laboratories
G61 1BD UK
UK
Name/email consistency: high
- HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Strathdee, G., Sim, A., Soutar, R., Holyoake, T.L., Brown, R. Carcinogenesis (2007)
- Epigenetic markers and response to chemotherapy in cancer. Strathdee, G. Dis. Markers (2007)
- Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy. Strathdee, G., Vass, J.K., Oien, K.A., Siddiqui, N., Curto-Garcia, J., Brown, R. Gynecol. Oncol. (2005)
- Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee, G., Davies, B.R., Vass, J.K., Siddiqui, N., Brown, R. Carcinogenesis (2004)
- Control of gene expression by CpG island methylation in normal cells. Strathdee, G., Sim, A., Brown, R. Biochem. Soc. Trans. (2004)
- Epigenetic versus genetic alterations in the inactivation of E-cadherin. Strathdee, G. Semin. Cancer Biol. (2002)
- Aberrant DNA methylation in cancer: potential clinical interventions. Strathdee, G., Brown, R. Expert. Rev. Mol. Med (2002)









